A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in atrial fibrillation

A randomized controlled trial of intravenous magnesium sulphate as an adjunct to standard therapy in atrial fibrillation

Magnesium sulphate (MgSO4) has been proven as an analgesic, neuromuscular blocker agent, and treatment of acute asthma.

Bibliographic Details
Main Authors: Raghu K, Ramakrishnan TV, Sreedevi G, Shreevani P, Gopala Krishna S, Ravishankar B
Format: Article
Language:English
Published: Sciendo 2022-08-01
Series:Acta Medica Martiniana
Subjects:
atrial fibrillation
magnesium sulphate
heart rate
sinus rhythm
Online Access:https://doi.org/10.2478/acm-2022-0011

Similar Items

Similar Items